About Enhancer
| Enhancer ID: | E_00056 |
| Species: | Homo sapiens |
| Position : | chr14:23915187-23917391   |
| Year: | 2021 |
| Title: | Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | cardiomyopathy |
| PMID: | 33478249 |
| MONDO: | MONDO:0004994 |
| Tissue: | left cardiac ventricle |
| Tissue Ontology ID: | UBERON:0002084 |
| Cell Source: | human iPSC-derived cardiomyocytes |
| Cell Type: | ventricular cardiomyocyte |
| Cell Ontology ID: | CL:0000746 |
| Experiment Type: | Enhancer activity assay; Functional perturbation assay; Regulatory variant functional assay |
| High Throughput Method: | Promoter Capture Hi-C; H3K27ac ChIP-seq; ATAC-seq; H3K4me3 ChIP-seq; CTCF ChIP-seq; cardiac TF ChIP-seq; gnomAD variant filtering; GTEx eQTL analysis |
| Low Throughput Method: | Luciferase reporter assay; CRISPR-Cas9 enhancer deletion; RT-qPCR; engineered heart tissue functional assay |
About Target Gene
| Target gene : | MYH7 |
About TF
| TF name : | NA |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
3 found
Expression of Target Genes for the Enhancer